Abstract:As one of the most important organelles in most eukaryotic cells,mitochondria not only supply cellular energy,but also involve in a range of other processes,such as cellular differentiation,cell death,as well as the control of the cell cycle and cell growth.Besides,cancer cell mitochondria exhibit an extensive metabolic activity and are more susceptible to mitochondrial perturbation than normal cell mitochondria.Consequently,induction of apoptosis through targeting of mitochondria of cancer cells can be an effective therapy strategy.Here,we conducted a hierarchical targeted delivery system that could deliver the chemotherapeutic agents,resveratrol (1),sequentially to tumor cells and mitochondria.In detail,the mitochondrial targeting prodrug triphenylphosphine-resveratrol (TPP-1) was constructed by conjugation.Then,the TPP-1 was entrapped in the lipid bilayer of liposomes.Followed,the liposomes were decorated with polyethylene glycol (PEG) and the cell targeting peptide RGD to form the hierarchical targeted delivery system (RLP-TPP-1 liposomes).The prepared RLP-TPP-1 liposomes were regularly spherical and well-distributed,the average particle size,ζ potential and encapsulation efficiency were (128.1±3.4) nm,(-20.28± 1.68) mV and (75.6±0.8) ％,respectively.The results of in vitro cytotoxicity test showed that the blank liposomes were nontoxic against MDA-MB-231 cells overexpressing αvβ3 receptors.However,the drug-loaded liposomes presented a significant inhibitory effect on MDA-MB-231 cells in a dose-dependent manner.In addition,the IC50 value (4.95 μmol/L) of the RLP-TPP-1 liposomes was the lowest among the tested liposomes.Cellular uptake experiment revealed that the uptake of RGD decorated liposomes were significantly higher than that of the undecorated liposomes.The results of JC-1 staining test showed that the RLP-TPP-1 liposomes performed the best mitochondrial targeting effect and increased apoptosis distinctively.In summary,RLP-TPP-1 liposomes could target to tumor cells and deliver 1 to mitochondria,resulting in the mitochondrial dysfunction and apoptosis of cancer cells.

Mitochondrial targeted hierarchical drug delivery system based on HA-modified liposomes for cancer therapy

Mitochondrial Targeted Doxorubicin-Triphenylphosphonium Delivered by Hyaluronic Acid Modified and pH Responsive Nanocarriers to Breast Tumor: in Vitro and in Vivo Studies.

Mitochondrial Targeting Nanodrugs Self-Assembled from 9-O-octadecyl Substituted Berberine Derivative for Cancer Treatment by Inducing Mitochondrial Apoptosis Pathways.

Mitochondria-Targeted Liposomes for Drug Delivery to Tumor Mitochondria

Preparation and Preliminary in vitro Evaluation of RGD Modified Mitochondrial Targeting Long-circulating Liposomes

Mitochondrial Targeted Doxorubicin Derivatives Delivered by ROS-responsive Nanocarriers to Breast Tumor for Overcoming of Multidrug Resistance.

Hierarchical Targeted Hepatocyte Mitochondrial Multifunctional Chitosan Nanoparticles for Anticancer Drug Delivery.

Mitochondria-targeted drug delivery system for cancer treatment.

Delivery of Mitochondriotropic Doxorubicin Derivatives Using Self-Assembling Hyaluronic Acid Nanocarriers in Doxorubicin-Resistant Breast Cancer

Long-Circulating Amphiphilic Doxorubicin For Tumor Mitochondria-Specific Targeting

Mitochondria-targeted Drug Delivery System for Cancer Treatment

Endosomal pH, Redox Dual-Sensitive Prodrug Micelles Based on Hyaluronic Acid for Intracellular Camptothecin Delivery and Active Tumor Targeting in Cancer Therapy

Stepwise Dual Targeting and Dual Responsive Polymer Micelles for Mitochondrion Therapy.

Overcoming drug-resistant lung cancer by paclitaxel-loaded hyaluronic acid-coated liposomes targeted to mitochondria.

Eph A10-modified pH-sensitive liposomes loaded with novel triphenylphosphine–docetaxel conjugate possess hierarchical targetability and sufficient antitumor effect both in vitro and in vivo

Mitochondrion-specific Dendritic Lipopeptide Liposomes for Targeted Sub-Cellular Delivery

Nanoplatform based on GSH-responsive mesoporous silica nanoparticles for cancer therapy and mitochondrial targeted imaging

Tumor acidity activated triphenylphosphonium-based mitochondrial targeting nanocarriers for overcoming drug resistance of cancer therapy

Hyaluronic Acid Modified Liposomes for Targeted Delivery of Doxorubicin and Paclitaxel to CD44 Overexpressing Tumor Cells with Improved Dual-Drugs Synergistic Effect

Hierarchical Targeted Delivery of Lonidamine and Camptothecin Based on the Ultra-Rapid Ph/gsh Response Nanoparticles for Synergistic Chemotherapy

Mitochondria-Specific Anticancer Drug Delivery Based on Reduction-Activated Polyprodrug for Enhancing the Therapeutic Effect of Breast Cancer Chemotherapy.